Cytokine profiling in patients with polypoidal choroidal vasculopathy before and after intravitreal injection of ranibizumab.
暂无分享,去创建一个
Minli Wang | Jianhao Bai | Tingting Sun | Qing Peng | Le Liu
[1] Muna Bhende,et al. Polypoidal choroidal vasculopathy: Pearls in diagnosis and management , 2018, Indian journal of ophthalmology.
[2] A. Tsujikawa,et al. Five-year visual outcomes after anti-VEGF therapy with or without photodynamic therapy for polypoidal choroidal vasculopathy , 2018, British Journal of Ophthalmology.
[3] J. Connolly,et al. Dataset of plasma and aqueous humor cytokine profiles in patients with exudative age related macular degeneration and polypoidal choroidal vasculopathy , 2018, Data in brief.
[4] T. Wong,et al. Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management. , 2018, Ophthalmology.
[5] Y. Teo,et al. Shared genetic variants for polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration in East Asians , 2017, Journal of Human Genetics.
[6] C. Cheung,et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians , 2016, Progress in Retinal and Eye Research.
[7] J. Prestegard,et al. Interactions of the Chemokine CCL5/RANTES with Medium-Sized Chondroitin Sulfate Ligands. , 2015, Structure.
[8] Min Zhao,et al. Interleukin-1β Level Is Increased in Vitreous of Patients with Neovascular Age-Related Macular Degeneration (nAMD) and Polypoidal Choroidal Vasculopathy (PCV) , 2015, PloS one.
[9] A. Luster,et al. Chemokines and chemokine receptors: positioning cells for host defense and immunity. , 2014, Annual review of immunology.
[10] L. Yao,et al. Roles of the Chemokine System in Development of Obesity, Insulin Resistance, and Cardiovascular Disease , 2014, Journal of immunology research.
[11] Takashi Baba,et al. Associations of IL-23 with polypoidal choroidal vasculopathy. , 2012, Investigative ophthalmology & visual science.
[12] H. Kuo,et al. High Glucose-treated Macrophages Augment E-Selectin Expression in Endothelial Cells* , 2011, The Journal of Biological Chemistry.
[13] F. Mach,et al. CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke , 2010, Thrombosis and Haemostasis.
[14] K. Clément,et al. CCL5 Promotes Macrophage Recruitment and Survival in Human Adipose Tissue , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[15] Wen-Chuan Wu,et al. Polypoidal choroidal vasculopathy in Taiwanese patients. , 2009, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[16] L. Yeung,et al. Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results , 2009, British Journal of Ophthalmology.
[17] M. Teixeira,et al. Role of the chemokines CCL3/MIP-1 alpha and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice. , 2009, Microvascular research.
[18] T. Ogihara,et al. Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular reactive oxygen species. , 2009, Journal of molecular and cellular cardiology.
[19] I. Maruko,et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. , 2007, American journal of ophthalmology.
[20] K. Alitalo,et al. Molecular regulation of angiogenesis and lymphangiogenesis , 2007, Nature Reviews Molecular Cell Biology.
[21] F. Wen,et al. Subtype lesions of neovascular age-related macular degeneration in Chinese patients , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[22] W. Buhre,et al. Differential and additive effects of platelet‐derived chemokines on monocyte arrest on inflamed endothelium under flow conditions , 2005, Journal of leukocyte biology.
[23] S. Stacker,et al. Molecular regulation of the VEGF family – inducers of angiogenesis and lymphangiogenesis , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[24] M. Matsumura,et al. Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy , 2004, British Journal of Ophthalmology.
[25] M. Ratajczak,et al. CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. , 2002, Blood.
[26] Y. Miyake,et al. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation , 2002, The British journal of ophthalmology.
[27] B. Lafaut,et al. Polypoidal choroidal vasculopathy in Caucasians , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.
[28] D. S. Garrett,et al. High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. , 1994, Science.
[29] G. Pagès,et al. VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing. , 2015, Methods in molecular biology.
[30] K. Clément,et al. CCL 5 Promotes Macrophage Recruitment and Survival in Human Adipose Tissue , 2009 .
[31] L A Yannuzzi,et al. IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV) , 1990, Retina.